Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.
Ontology highlight
ABSTRACT: Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract symptoms that resemble interstitial cystitis. The pathophysiology of ketamine-induced cystitis (KC) is largely unknown and effective therapies are lacking. Here, using a KC rat model, we show the therapeutic effects of human umbilical cord-blood (UCB)-derived mesenchymal stem cells (MSCs). Daily injection of ketamine to Sprague-Dawley rats for 2-weeks resulted in defective bladder function, indicated by irregular voiding frequency, increased maximum contraction pressure, and decreased intercontraction intervals and bladder capacity. KC bladders were characterized by severe mast-cell infiltration, tissue fibrosis, apoptosis, upregulation of transforming growth factor-β signaling related genes, and phos
SUBMITTER: Kim A
PROVIDER: S-EPMC4969614 | biostudies-literature | 2016 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA